Impact of dabigatran on routine and specific coagulation assays in patients treated by dabigatran.

被引：0
|
作者：
Gemen, E. [1 ]
Kariman, A. [1 ]
Van Dijk, J. [1 ]
Van Eck, M. [1 ]
Pequeriaux, N. [1 ]
机构：
[1] Jeroen Bosch Hosp, Shertogenbosch, Netherlands
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2013年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：701 / 702
页数：2
相关论文
共 50 条
  • [1] Impact of dabigatran on a large panel of routine or specific coagulation assays Laboratory recommendations for monitoring of dabigatran etexilate
    Douxfils, Jonathan
    Mullier, Francois
    Robert, Severine
    Chatelain, Christian
    Chatelain, Bernard
    Dogne, Jean-Michel
    THROMBOSIS AND HAEMOSTASIS, 2012, 107 (05) : 985 - 997
  • [2] Dabigatran assessment in patients with acute complications using routine coagulation assays
    Stang, Linda
    Nahirniak, Susan
    Butcher, Ken
    Szkotak, Artur J.
    BLOOD COAGULATION & FIBRINOLYSIS, 2014, 25 (05) : 426 - 434
  • [3] Influence of dabigatran and rivaroxaban on routine coagulation assays A nationwide Belgian survey
    Van Blerk, Marjan
    Bailleul, Els
    Chatelain, Bernard
    Demulder, Anne
    Devreese, Katrien
    Douxfils, Jonathan
    Jochmans, Kristin
    Mullier, Francois
    Wijns, Walter
    Soumali, Mohamed Rida
    Coucke, Wim
    Vernelen, Kris
    Van de Walle, Philippe
    THROMBOSIS AND HAEMOSTASIS, 2015, 113 (01) : 154 - 164
  • [4] Specific Point-of-Care Testing of Coagulation in Patients Treated with Dabigatran
    Haertig, Florian
    Birschmann, Ingvild
    Peter, Andreas
    Ebner, Matthias
    Spencer, Charlotte
    Gramlich, Michael
    Richter, Hardy
    Kuhn, Joachim
    Lehmann, Rainer
    Blumenstock, Gunnar
    Zuern, Christine S.
    Ziemann, Ulf
    Poli, Sven
    THROMBOSIS AND HAEMOSTASIS, 2021, 121 (06) : 782 - 791
  • [5] The adsorption of dabigatran is as efficient as addition of idarucizumab to neutralize the drug in routine coagulation assays
    Jacquemin, M.
    Toelen, J.
    Feyen, L.
    Schoeters, J.
    Van Horenbeeck, I.
    Vanlinthout, I.
    Debasse, M.
    Vanassche, T.
    Peerlinck, K.
    Verhamme, P.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2018, 40 (04) : 442 - 447
  • [6] Dabigatran: Is There a Role for Coagulation Assays in Guiding Therapy?
    Brunetti, Luigi
    Bandali, Farooq
    ANNALS OF PHARMACOTHERAPY, 2013, 47 (06) : 828 - 840
  • [7] The Effect of Dabigatran on Select Specialty Coagulation Assays
    Adcock, Dorothy M.
    Gosselin, Robert
    Kitchen, Steve
    Dwyre, Denis M.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2013, 139 (01) : 102 - 109
  • [8] Influence of dabigatran on coagulation assays, an 'in vitro' study
    Samama, M. M.
    Guinet, C.
    Gerotziafas, G.
    Le Flem, L.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 18 - 19
  • [9] Coagulation assays and plasma fibrinogen concentrations in real-world patients with atrial fibrillation treated with dabigatran
    Chin, Paul K. L.
    Patterson, David M.
    Zhang, Mei
    Jensen, Berit P.
    Wright, Daniel F. B.
    Barclay, Murray L.
    Begg, Evan J.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 78 (03) : 630 - 638
  • [10] Effects of Dabigatran and Rivaroxaban On Routine and Specialized Coagulation Assays: A Study Using Actual Patient Plasma Samples
    Smith, Tyler W.
    Zypchen, Leslie
    Carter, Cedric J.
    Annie Tran
    Colley, Pamela
    Gin, Kenneth
    Teal, Philip
    Masri, Bassam A.
    Lee, Agnes Y. Y.
    BLOOD, 2012, 120 (21)
12345